Skip to main content

Blink Charging Advancing Fast Charging in Q1 2026

136 DC fast charging stalls approved or underway in the first 90 days of the year, doubling down on its DCFC Owner Operator focus  Bowie, MD, May 13, 2026 (GLOBE NEWSWIRE) — Blink Charging Co. (NASDAQ: BLNK) (“Blink” or the “Company”), a leading global owner, operator, and provider of electric vehicle (EV) charging equipment and services, today highlighted the strong momentum in its DC fast charging (DCFC) infrastructure expansion during the first quarter of 2026, as the Company continues to deliver on its strategy to expand its owned and operated fast charging sites, supporting long-term, repeatable revenue growth. As of March 31, 2026, Blink advanced a focused pipeline of DCFC sites progressing across several active stages of development, including 27 sites approved or under construction. Upon completion, these sites are expected...

Continue reading

Cannabix Marijuana Breath Test Achieves Major Milestone: Breath Collection Unit Secures UL and CSA Certifications

VANCOUVER, British Columbia, May 13, 2026 (GLOBE NEWSWIRE) — Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) is pleased to announce that its portable Breath Collection Unit (BCU), a core component of the Company’s Marijuana Breath Test (MBT), has successfully achieved Underwriters Laboratories (UL) and Canadian Standards Association (CSA) electrical safety certifications. The BCU along with Cannabix’s proprietary Breath Cartridges are core hardware products of the MBT system (Figures 1 and 2). The Cannabix BCU has been certified to UL 61010-1 (United States) and CSA 61010-1-12 (Canadian) standards which are recognized North American safety standards that confirm a device is safe and suitable for professional, industrial, and regulated use. Testing and certification were completed...

Continue reading

ParaZero Demonstrates Advanced Counter Drone Solution at BSDA Exhibition in Romania for NATO Officials and Military Leadership

Kfar Saba, Israel, May 13, 2026 (GLOBE NEWSWIRE) — ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, today announced the successful demonstration of its DefendAir solution during the Black Sea Defense, Aerospace and Security (BSDA) exhibition in Romania. The live demonstration was conducted in collaboration with ParaZero’s regional reseller, New Akord Security, as part of a comprehensive “Modern Battlefield Simulation.” The event showcased a multi-layered defense ecosystem involving leading drone manufacturers, robotics, and counter-measure solutions. The simulation was attended by over 200 high-ranking officials and key stakeholders, including: Senior NATO Officers,...

Continue reading

Anteris Appoints Susan Knight and Stephen Denaro to its Board of Directors

MINNEAPOLIS and BRISBANE, Australia, May 13, 2026 (GLOBE NEWSWIRE) — Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, announced the appointment of Ms. Susan Knight and Mr. Stephen Denaro to serve on the Board of Directors (the “Board”). “On behalf of the management team and Board, I am delighted to welcome Sue to the Company,” commented John Seaberg, Chairman of Anteris. “I am also delighted to welcome back Stephen, whose familiarity with our business and strong governance expertise make him a tremendous asset to the Board. Together, they further strengthen our leadership at an exciting time for the Company as we advance the DurAVR® global,...

Continue reading

Xeriant Signs Letter of Intent for Priority Supply of Advanced Mineral Components for its Proprietary Fire-Retardant Technology

Strategic Partnership Strengthens Supply Chain and Enhances Fire Performance for NexBoard™ and NexPatch™ BOCA RATON, Fla., May 13, 2026 (GLOBE NEWSWIRE) — Xeriant, Inc. (OTCQB: XERI), a company dedicated to the discovery, development, and commercialization of transformative technologies, today announced it has signed a Letter of Intent (LOI) with a mineral mining company, establishing Xeriant as a Priority Commercial Partner for the exclusive supply of unique mineral components used in Xeriant’s proprietary fire-retardant formulations. Under the LOI, Xeriant will have priority access to specific high-quality minerals that are being used in its intumescent fire-retardant chemistry. These minerals enhance the performance of NexBoard™ composite construction panels and the newly launched NexPatch™ fire-resistant...

Continue reading

EpicQuest Education Chairman & CEO Letter to Shareholders

TOLEDO, Ohio, May 13, 2026 (GLOBE NEWSWIRE) — EpicQuest Education Group International Limited (Nasdaq: EEIQ), (“EpicQuest Education”, “EEIQ” or the “Company”), a provider of higher education for domestic and international students in the US, Canada and the UK, today announced a Letter to Shareholders from its Chairman and CEO. “We are proud to be a next-generation higher educational company, delivering results-driven learning experiences to students worldwide,” stated EpicQuest Education Chairman and CEO Jianbo Zhang. “By fostering a culture of innovation and a collaborative work environment, we have adapted to an evolving education landscape shaped by online learning and the transformative power of AI.” “For those of you who are new to our Company, we began by recruiting for the English Language Center of Miami University of Ohio,...

Continue reading

ASUS Republic of Gamers to Celebrate 20 Years of Gaming Innovation at Computex 2026

ROG marks its 20th anniversary with a press event, special edition products, and a celebration driven by the For Those Who Dare spirit KEY POINTS20 years of gaming excellence: A press event honoring two decades of innovation shaped with the gaming community Anniversary innovations: ROG Lab, special edition products, and breakthrough technologies mark a major milestone for ROG Gaming community celebration: Demo areas, a party, and community experiences highlight the For Those Who Dare spiritTORONTO, May 13, 2026 (GLOBE NEWSWIRE) — ASUS Republic of Gamers (ROG) today announced its upcoming ROG Press Event and Party at Computex 2026, marking its 20th anniversary and ushering in a new era of gaming innovation. Taking place on June 1 from 5.00–10.00 p.m. (GMT+8) at Syntrend Creative Park in Taipei, the event will bring together...

Continue reading

SS Innovations Reports First Quarter 2026 Financial Results

Record quarterly revenue driven by strong growth in SSi Mantra installations and procedures FORT LAUDERDALE, Fla., May 13, 2026 (GLOBE NEWSWIRE) — SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced unaudited financial results for the three months ended March 31, 2026. The Company also filed its Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, with the Securities and Exchange Commission on May 13, 2026. First Quarter 2026 OverviewRevenue increased 116.8% to $11.1 million from $5.1 million in the first quarter of 2025. Gross margin expanded to 48.0% from 21.2% in the first quarter of 2025. Gross profit rose 390.0% to $5.3...

Continue reading

Fate Therapeutics Reports First Quarter 2026 Financial Results and Business Updates

RECLAIM – LN, a Phase 2 potentially registrational clinical trial of FT819 in patients with refractory moderate-to-severe systemic lupus erythematosus (SLE) with lupus nephritis, on schedule to initiate in the 2nd half of 2026 FDA selects FT819 into the CDRP (CMC Development and Readiness Pilot) program enabling early and enhanced communication with the FDA to ensure CMC readiness for accelerated clinical timelines Clinical data presented at Pediatric Rheumatology Symposium 2026 and Congress of Clinical Rheumatology – East 2026 highlights safety and efficacy of single dose of FT819 with reduced conditioning in SLE Preclinical data presented at the American Association for Cancer Research 2026 demonstrates the unique ability of FT839 for comprehensive targeting of hematological malignancies and autoimmune diseases without the use of conditioning...

Continue reading

Intelligent Bio Solutions Reports Fiscal Third Quarter Revenue Growth of 46% Year-over-Year

Razor-razorblade business model accelerates, with Q3 cartridge revenue up 59% year-over-year, representing 66% of quarterly sales Nine-month revenue reaches $3.07 million, up 39% year-over-year, building on record first-half performance Gross profit margin expands to 50.5% in Q3 and 49.3% for the nine months, improving approximately 800 basis points year-over-year for the nine-month period NEW YORK, May 13, 2026 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its financial results and operational highlights for the fiscal third quarter and nine months ended March 31, 2026, and provided a business update. “The third quarter marked another period of strong...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.